Drug Approval | October 27, 2022
Zydus gets USFDA’s approval for Ketorolac Tromethamine Tablets
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
The CRL did not identify any outstanding scientific issues with the product.
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
NABH shall encourage and provide assistance in onboarding their accredited/certified facilities on ABDM’s Health Facility Registry
Roflumilast Tablets had annual sales of US $248 million in the United States according to IQVIA data
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
Valbenazine Capsules had annual sales of US $781 million in the United States according to IQVIA data
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
Dr. Reddy’s largest manufacturing facility in Bachupally, Hyderabad, joins Global Lighthouse Network of the World Economic Forum
_256_384.png)
Amongst the first pharmaceutical companies in India and Asia to be recognised for adopting advanced fourth industrial revolution technologies to digitally transform operations
Subscribe To Our Newsletter & Stay Updated
